BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
GATA1
,
calcium channel activity
,
Inflammatory disorder
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LAGE-2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Uterine cancer
Tuberculosis
Pancreatic cancer
Neuroendocrine tumor
Lung cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ions
AR A014418
styrene oxide
benz(a)anthracene
ethyl protocatechuate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
KAT5
TAF1
LGALS4
NPM1
PRL
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and…
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analy…
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightf…
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and anti…
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in C…
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells …
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-…
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Eso…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ